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Abstract
Objectives The objective of this study was to assess correct use of inhaler devices,
adherence to inhaler corticosteroid treatment and their effects on asthma control.
Methods This study was a prospective, single-centre, observational study conducted
between July and February 2016 at Al-Makased Hospital, respiratory outpatient clinic.
Inhaler technique of asthma patients using pressurized metered-dose inhalers or dry pow-
der inhalers (Turbuhaler (TH) and Accuhaler DiskusTM (ACC)) were assessed against
published inhaler technique checklists. Asthma control variables measured using Asthma
Control Test (maximum 25, higher score corresponding to better asthma control) were
assessed, and adherence to asthma medications was assessed by Morisky adherence scale.
Key findings Two hundred and twenty patients were recruited in the study. The mean
age was 42.3  15.2 years and 59.1% were male. One hundred and seventeen (53.2%)
were using TH, 60 (27.3%) were using ACC and 43(19.5%) were using MDIs. Only 22
(10%) were smoker and only 48 (21.8%) patients were their asthma controlled (ACT
score >20). The devices were used correctly by 79.1% of patients using MDI, 69% of
ACC and 55.6% of TH users (P > 0.001). The most common improper step was ‘forceful
inhalation’ (65.4%) made by the MDI users, ‘Not exhaling to residual volume’ (58.7%)
made by ACC users and ‘Not inhaling deeply enough’ (52.2%) made by TH users. Mul-
tivariate analysis showed that the likelihood of having controlled asthma was signiﬁcantly
higher in those with correct inhaler techniques (OR 2.3; 95% CI: 1.08–4.77; P = 0.028),
high adherence to medications (OR 2.37; 95% CI: 1.05–4.92; P = 0.03) and having a
higher level of education (OR 2.58; 95% CI: 1.19–3.63; P = 0.018).
Conclusions It was found that asthma control was better among correct users. Repeti-
tive training about using devices may contribute improving inhaler technique.
Keywords adherence; Asthma Control Test; counselling; inhaler technique; Palestine;
patient education
Introduction
Asthma is a chronic disease condition that causes major symptoms for the patient and
affects livelihood, productivity and schooling with staggering cost for the healthcare sys-
tem and cost of medications on community and individuals.[1,2] The number of asthma
patients varies per country but in general, the prevalence can be as high as 5–23% in ‘de-
veloped countries’.[3,4] Comparison of different studies in the Middle East indicates that
the prevalence in rural Palestinian areas appears to be the lowest at 5.5% (as measured
by 12 months wheezing rate),[5] while the highest prevalence was reported in Saudi Ara-
bia desert population (23%).[6] In Palestine, the prevalence of recent wheezing was 8.9%
and the prevalence of physician-diagnosed asthma was 3.8%.[5] Results from Jordan indi-
cate a similar trend, where the prevalence for reported-wheezing was 8.3 and 4.1% for
physician-diagnosed asthma.[4]
Patients commonly depend on inhalation devices during the maintenance phase of
Asthma treatment. Pressurized metered-dose inhalers (pMDIs) and dry powder inhalers
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(DPIs) are the two types of devices commonly used by
patients. Asthma control has been shown to be related to
proper technique of inhaler use, with improper use resulting
in poor asthma control, increased cost of treatment and
more frequent hospital visits.[7–9] Side effects may also
increase due to upper airway deposition of medication. This
may result in overall patient dissatisfaction less than optimal
response, ultimately resulting in poor medication adher-
ence.[10,11] Speciﬁc steps need to be done when using an
inhaler device; the steps need to be performed correctly to
ensure optimal response.[12,13]
Approximately 75% of patients made at least one error
with using an MDI and 50–60% of the DPI patients made
one error at least.[14–16] Unfortunately, healthcare profes-
sional’s ability to use asthma inhaler devices showing a
similar propensity to patients for at least one error (13–
80%).[17–19] This highlights the necessity for the healthcare
provider to better understand inhaler techniques to allow
them to pass the information to asthma patients.
The primary objective of the present study was to evalu-
ate inhaler technique in outpatient asthma patient and the
relationship to asthma control and patient’s adherence to
inhalers.
Materials and methods
Study design and subjects
This was a single-centre prospective observational study
conducted at respiratory outpatient clinic of Al-Maqsed
Hospital in East Jerusalem. The study was approved by Al-
Maqsed Hospital institutional review board (PT-15/June/
2015).
Patient’s inclusion criteria included physician-diagnosed
asthma, age >18 years and currently using one of the fol-
lowing inhalation devices: pressurized metered-dose inhaler
(pMDI), Turbuhaler (TH) or Accuhaler (ACC). The
devices contained maintenance medications (inhaled corti-
costeroids (ICS) with or without long-acting Beta agonist
(LABA)) and patients having been on the device for at least
6 months. Study exclusion criteria included patients having
cognitive impairment or suffering from a co-morbid condi-
tion. Before participating in the study, eligible patients
signed an Informed Consent Form.
Asthma control
Asthma Control was deﬁned as patients having no asthma
symptoms, no limitation of daily activities, normal pul-
monary function and no exacerbations.[20] ACT scoring sys-
tem was used to measure asthma control; this system
includes ﬁve questions, and the patient had to select one of
ﬁve possible answers for each question.[21] Answers were
assigned a score of 1–5, with a minimum total score of 5
and a maximum of 25. Patients with a score of 20 or higher
are considered to be under control, while a total score of
<20 are considered uncontrolled. The ACT scoring system
is a commonly used tool in asthma research. The tool is dis-
tributed by GSK and is available in Arabic.[22,23] Verbal
approval for the use of the ACT scoring system was
obtained from the local GSK Ofﬁce.
Inhaler technique assessment
The researcher with experience in inhaler technique education
assessed inhalation technique in all patients using validated
inhaler technique checklists for TH, ACC and pMDI. Each
device had checklists of nine steps each; three steps were con-
sidered ‘essential’ for ACC and pMDI while TH had four
essential steps (Table 1). The patient’s technique was consid-
ered ‘correct’ if the required essential steps were performed
accurately per inhaler and ‘incorrect’ if the essential steps
were performed inaccurately or totally missed.[12,24,25] Once
the trial assessments were completed, all patients were edu-
cated about the correct inhaler technique.
Adherence to control medications
The four Yes/No questions Morisky scale was used to mea-
sure adherence. The tool reﬂects the factors that affect
Table 1 Technique checklists for the DPIs and the pMDI*
AccuhalerTM (Diskus)
Step Description/action
1 Open inhaler†
2 Push lever back completely†
3 Exhale to residual volume
4 Exhale away from mouthpiece
5 Place mouthpiece between teeth and lips
6 Inhale forcefully and deeply†
7 Hold breath for 5 s
8 Exhale away from mouthpiece
9 Close inhaler
Turbuhaler
Step Description/action
1 Remove the cap from the inhaler†
2 Keep inhaler upright†
3 Rotate grip until a click is heard†
4 Exhale to residual volume
5 Exhale away from mouthpiece
6 Place mouthpiece between teeth and lips
7 Inhale forcefully and deeply†
8 Hold breath for 5 s†
9 Exhale away from mouthpiece
pMDI
Step Description/action
1 Remove mouthpiece cover and shake†
2 Hold inhaler upright
3 Exhale to residual volume
4 Keep head upright or slightly tilted
5 Place mouthpiece between teeth and lips
6 Inhale slowly and press canister†
7 Continue slow and deep inhalation†
8 Hold breath for 5 s
9 Close the inhaler
DPI, dry powder inhaler; pMDI, pressurized metered-dose inhaler.
*These checklists and essential steps are in accordance with the litera-
ture.[12,24]
†Essential step: if not performed correctly, little/no medication will
reach the lung.[25]
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adherence: forgetting, carelessness, stopping when feeling
better and stopping when feeling worse. On scoring of the
questionnaire, each ‘yes’ response is given a score of 1 and
each ‘no’ response is given a score of 0. As such, the
adherence scores can range from 0 to 4; adherence classiﬁ-
cations was either low adherence (scores of 2–4) or high
adherence (scores of 0–1). Validity of Morisky self-report
adherence scale has been well-established.[26] A pilot study
was done on 10 patients from Al-Makassed hospital, Cron-
bach’s Alpha for all 0.81 a good internal consistency and
reliability.
A special form was used to capture data that included
patient’s name, sex, age, education, inhabitance, occupation,
marital status and smoking habits. In addition, type of inha-
ler device used, education of inhaler technique and fre-
quency of use were also collected. The study was
conducted by a single investigator (trained in device use),
in order to eliminate variability.
Statistical analysis
Data were collected and analysed by the computer software
Statistical Package for Social Sciences Personal Computer
(SPSSPC, Version 18.0. SPSS Inc, Chicago, IL, USA).
The v2 test was used to compare categorical data. Mann–
Whitney U-test was used for variables that were not nor-
mally distributed. Univariate logistic regression analyses
were performed, the variables with P values <0.25 in uni-
variate analyses were evaluated with multivariate analyses.
Statistical signiﬁcance was deﬁned as P value <0.05
(P < 0.05).
Results
Two hundred and twenty patients were interviewed. Some
demographic and clinical characteristics of studied patients
are displayed in Table 2. The mean age of patients was
42.3  15.3 years and 130 (59.1%) of patients were female.
One hundred and seventeen (53.2%) were using Tur-
buhaler(T), 60 (27.3) were using Accuhaler and 43 (19.5%)
were using MDIs. Only 22 (10%) were smoker, and only
48 (21.8%) patients were under control as measured by
ACT.
The majority of the patients (Accuhaler 82%,
Turbuhaler 77% and metered-dose inhalers 71%) agree
that the use of their inhalers is essential to manage
their asthma symptoms, with no signiﬁcant differences
between inhaler groups (P = 0.41). The majority of
patients reported obtaining information on inhaler tech-
niques from their specialist (69%), followed by the hospi-
tal clinic (49%), with no signiﬁcant difference between
groups (P > .0.05).
Inhaler technique was correct in 79% of pMDI users,
69% of Accuhaler users and 55% of Turbuhaler users (Fig-
ure 1). Inhalation technique scores (of a total of 9 for all
devices) were lower for Turbuhaler (5.3) and Accuhaler
(6.2) compared to the metered-dose inhalers (7.7). A signiﬁ-
cant difference was found between the different inhaler
groups (P = 0.001; Table 2).
Most common errors made by the MDI users were ‘force-
ful inhalation’ (65.4%), ‘No/Short Breath hold’ (63.5%).
Accuhaler users were ‘Not exhaling to residual volume’
(58.7%), ‘Exhale a way from mouthpiece’, and Tur-
buhaler users were ‘Not inhaling deeply enough’ (52.2%;
Figure 2).
More error was identiﬁed in old patients >60 years using
a device for more than 5 years (87%) while minimum
(51%) in young patients <40 years (P < 0.05). A compar-
ison of education data showed patients with higher educa-
tion committed less errors (P < 0.05).
Overall, only 21.8% of patients were classiﬁed as hav-
ing controlled asthma (ACT score ≥20). ACT scores
Table 2 Patients demographics and asthma management characteristics
Characteristics of patients Turbuhaler (n = 117) (n, %) Accuhaler (n = 60) (n, %) pMDI (n = 43) (n, %) P value
Female 72 (61.5) 34 (56.7) 24 (55.8) 0.78
Age (years) 43.8  15.3 41.2  13.1 39.5  12.5 0.90
Duration of asthma diagnosis (years  SD) 11.1  6.6 8.9  6.0 9.5  6.8 0.66
Asthma control*
ACT (controlled) 25 (21.4) 14 (23.3) 9 (20.9) 0.88
ACT (uncontrolled) 92 (78.6) 46 (76.7) 34 (79.1)
Adherence†
High adherence 72 (61.6) 35 (58.3) 25 (58.2) 0.90
Low adherence 45 (38.4) 25 (41.7) 18 (41.8)
Inhaler technique score, mean  SD 5.3 (0.9) 6.2 (0.8) 7.7 (0.9) 0.001
Smoker 11 (9.4) 9 (15.0) 4 (9.30) 0.66
Ex-smoker 53 (45.3) 29 (48.3) 22 (51.2)
Non-smoker 53 (45.3) 22 (36.7) 17 (39.5)
Education
Primary education 9 (7.7) 1 (1.7) 9 (20.9) 0.04
Secondary education 48 (41.0) 33 (55.0) 18 (41.9)
University/College 60 (51.3) 26 (43.3) 16 (37.2)
*ACT score out of 25: ≥20 controlled; <25 uncontrolled asthma.
†Adherence scores can range from 0 and 4: scores of 0–1 (high adherence); scores of 2–4 (low adherence).
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showed no signiﬁcant difference between the three device
groups, disease duration or gender P = 0.56, 0.96, and
0.33 respectively (Table 2). Multivariate analysis mod-
elling showed that having a higher level of education
was signiﬁcantly associated with having better asthma
control (OR 2.58; 95% CI: 1.19–3.63; P = 0.018;
Table 3).
Of the 48 patients with asthma control, 37 (77.1%)
showed correct inhaler techniques. Similarly, 116 (67.4%)
of the patients with poor inhaler technique had poor asthma
control. Multivariate analysis showed that the likelihood of
having controlled asthma was signiﬁcantly higher in those
with correct inhaler techniques (OR 2.3; 95% CI: 1.08–
4.77; P = 0.028; Table 3).
Adherence to control medication was high in 135 (60%)
and low in 88 (40%) of the participants. There were no sig-
niﬁcant differences in adherence between genders (P
= 0.34). The most common causes reported of low adher-
ence were ‘forgetting to take the drug’ (51.3%) and ‘feeling
well, doesn’t need the drug’ (25.5%).
Figure 1 Percentage of correct inhaler users of each inhaler device.
Figure 2 Most common errors made by the pressurized metered-dose inhalers users, Turbuhaler users and Accuhaler users.
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A total of 29 (60.4%) of the patients with controlled
asthma had high adherence to their control medications.
Comparison of patients with low and high adherence, the
latter were found more likely to have controlled asthma
(OR 2.37; 95% CI: 1.05–4.92; P = 0.03, Table 3).
Discussion
Inhalational therapy constitutes the cornerstone of pharma-
cological management of asthma, metered-dose inhalers and
DPIs are commonly used in stable patients, while in an
acute attack physicians rely on administering the drugs via
nebulization. Improper use of these devices can negatively
affect their pulmonary delivery.[27] Therefore, in situations
where the drugs are not taken as prescribed or do not reach
the target area, it is likely that one might anticipate a poor
treatment control.
Previous studies have reported on the frequency of cor-
rect use of inhaler technique among asthma patients.[28,29] In
general, adequate performance was reported in 16.5–88% of
asthmatic patients.[30,31] Similarly, the frequency of correct
use of MDI and DPI devices were reported as 12–68%[32]
and 21.8–88%[33] respectively. A critical at the available data
suggests that the wide range of reported values may be
attributed to differences between study population and deﬁ-
nition of what is considered ‘incorrect use’.
The present study showed that the main source of patient
information about inhaler techniques comes from their spe-
cialist (69%), followed by the hospital clinic (49%). These
data were consistent with data provided by Basheer et al.[34]
in their study. The present study shows that 79% of the
total enrolled patients committed at least one error during
device usage. The data were consistent with another study
where at least one error was committed by 82.1% of
patients.[35] The most common errors were independent of
the device used, which include failure to exhale before drug
inhalation and failure to hold breath after inhalation. This is
in line with ﬁndings from previous studies.[16]
The data also showed that old patients >60 years and
those with poor or low education made maximum number
of errors. Consistent with our ﬁndings, Melani et al.[36]
observed inhalation technique of 1664 patients and found
risk of critical errors increased with age. A study by Gracia
et al.[37] that included 467 bronchial asthma patients
observed increased risk of error with lower level of educa-
tion. The ﬁnding above suggests that errors committed by
patients during device use maybe attributed to the fact that
the patient did not fully comprehend the instructions pro-
vided about inhaler technique. A more comprehensive train-
ing programme, keeping in mind the patient’s education,
age and level of comprehension, could address this issue.
One might anticipate that incorrect use of the inhalation
device may result in insufﬁcient drug delivery, which might
negatively affect asthma control. On the other hand, correct
use of inhaler devices improves asthma control in
adults.[27,38] Accordingly, the data indicate that a higher fre-
quency of asthma control can be observed in patients using
their device correctly (OR 2.37; 95% CI: 1.05–4.92;
P = 0.03). The importance of inhaler technique and its asso-
ciation with asthma control has been emphasized in the
2018 Global Initiative for Asthma strategy report[39,40] in
which patients with incorrect inhaler technique were more
likely to have poor asthma control.
In our study, 60% of patients showed high adherence to
inhaler therapy. This percentage needs to be considered with
caution because self-reported drug use does not always pre-
dict real adherence.[41] In previous studies among asthma
patients, non-adherence rate ranged between 22.8 and
82.6%.[42,43] Adherence to ICS is essential to drug effective-
ness. In present study, frequency of asthma control was
found to be higher in patients with high adherence to pre-
scribed ICS than patients of low adherence. This result is
consistent with literature reports showing that improved
patient adherence predicts superior asthma control and
improved patient quality of life.[29,44,45]
Reasons for low adherence are multifactorial that may
include social-, therapy- or patient-related factors.[45] In the
current study, the most reported reason for low adherence
was forgetting to take the drug. This issue should be dis-
cussed with the patient and can be easily addressed with
modern technology (like computer-based applications or cel-
lular phones) that provide ways to remind the patient to take
the medication. Another reported reason for low adherence
was if patients did not feel the need for the drug. Such
intentional low adherence may be addressed by correcting
patient misbelieves. Patient counselling with detailed discus-
sion about perceptions of patients and caregivers will likely
help.
Consistent with published data, the present study showed
that asthma control could be predicted by older age at
asthma onset and higher level of education. On the other
hand, lower level of education or poor inhaler technique is
associated with poor asthma control.[32]
Limitation
Medication adherence was measured using patient’s survey.
This method may not an objective measure of adherence.
More ideal measure would have been parameters like canis-
ter weight, prescription reﬁlls, drug assays or electronic
Table 3 The variables affecting asthma control
Variable* Univariate Multivariate
OR CI 95% P OR CI 95% P
Education
status (Higher)
2.77 1.41–5.26 0.004 2.58 1.19–3.63 0.018
Inhaler
technique
(Correct)
2.35 1.25–4.39 0.007 2.32 1.08–4.77 0.028
Adherence
(High)
2.25 1.22–4.36 0.011 2.37 1.05–4.92 0.030
Age > 1.51 1.10–2.44 0.041 1.32 0.66–2.88 0.311
Types of inhaler 1.22 0.73–2.51 0.568
Disease duration > 1.09 0.55–1.78 0.969
Gender (male) 1.33 0.71–2.81 0.338
*Signiﬁcant variables in univariate analysis were used in multivariate
analyses.
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monitoring.[6,27,38] Thus, responder’s bias may limit ﬁndings
about adherence to asthma treatment by inhalers.
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